Long-term colorectal-cancer mortality after adenoma removal.

Colorectal cancer. Nat Rev Dis Prim (2015) 1.07

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 1.01

The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci (2015) 0.96

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 0.95

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 0.90

Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study. EBioMedicine (2015) 0.87

Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy (2016) 0.84

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland. BMJ Open Gastroenterol (2015) 0.81

High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients. Oncotarget (2016) 0.79

Smoking status informs about the risk of advanced serrated polyps in a screening population. Endosc Int Open (2015) 0.79

The continuing uncertainty about cancer risk in inflammatory bowel disease. Gut (2016) 0.78

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J (2017) 0.78

Expert opinions and scientific evidence for colonoscopy key performance indicators. Gut (2016) 0.77

Endoscopic mucosal resection of large colorectal adenomas: Only for expert centers? United European Gastroenterol J (2015) 0.77

Long-term follow-up after removal of colorectal adenomas provides evidence for risk stratification of patients at colonoscopic polypectomy. Evid Based Med (2014) 0.77

Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation. Transl Oncol (2016) 0.77

Endoscopic mucosal resection of colorectal adenomas > 20 mm: Risk factors for recurrence. World J Gastrointest Endosc (2016) 0.76

Comparison of the diagnostic ability of blue laser imaging magnification versus pit pattern analysis for colorectal polyps. Endosc Int Open (2017) 0.75

Colon-polyp surveillance--do patients benefit? N Engl J Med (2014) 0.75

Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 0.75

Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas. PLoS One (2016) 0.75

Detection of colorectal dysplasia using fluorescently labelled lectins. Sci Rep (2016) 0.75

Detection of human papillomavirus infection by molecular tests and its relation to colonic polyps and colorectal cancer. Saudi Med J (2016) 0.75

Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut (2016) 0.75

Surveillance of colonic polyps: Are we getting it right? World J Gastroenterol (2016) 0.75

A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers. Clin Proteomics (2015) 0.75

[High risk despite polypectomy]. MMW Fortschr Med (2014) 0.75

Authors' response to Eluri et al. letter to the editor regarding: Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice. Int J Cancer (2015) 0.75

Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms. Onco Targets Ther (2016) 0.75

Complication and local recurrence rate after endoscopic resection of large high-risk colorectal adenomas of ≥3 cm in size. Int J Colorectal Dis (2016) 0.75

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2005) 16.35

Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34

Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med (2002) 10.64

Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06

Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst (2008) 8.62

Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78

Natural history of early, localized prostate cancer. JAMA (2004) 7.44

The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61

[In Process Citation]. Tidsskr Nor Laegeforen (2015) 6.35

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85

Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74

Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ (2012) 4.05

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy (2013) 4.03

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84

[More harm than benefit - how much should the patients know?]. Tidsskr Nor Laegeforen (2017) 3.82

Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ (2004) 3.67

Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55

Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol (2011) 3.45

The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44

A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst (2003) 3.29

Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst (2005) 3.19

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14

Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84

Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet (2002) 2.72

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71

Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62

Average energy intake among pregnant women carrying a boy compared with a girl. BMJ (2003) 2.55

Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49

Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol (2014) 2.35

Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol (2012) 2.28

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst (2006) 2.23

The socioeconomic gradient in the incidence of stroke: a prospective study in middle-aged women in Sweden. Stroke (2006) 2.23

Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19

Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18

Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08

Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99

[What should non-inferiority studies be called in Norwegian?]. Tidsskr Nor Laegeforen (2014) 1.98

A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.97

The capsule and colorectal-cancer screening--the crux of the matter. N Engl J Med (2009) 1.95

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res (2004) 1.91

Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88

Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2007) 1.87

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev (2004) 1.82

Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79

Multiple myeloma: a review of the epidemiologic literature. Int J Cancer (2007) 1.78

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77

Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst (2006) 1.68

Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol (2007) 1.68

Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev (2005) 1.66

Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev (2011) 1.61

Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer (2012) 1.61

Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol (2003) 1.59

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58

Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. BMJ (2008) 1.57

Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev (2010) 1.56

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst (2005) 1.55

Colonoscopy as a triage screening test. N Engl J Med (2012) 1.55

Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev (2002) 1.54

Screening for colorectal cancer. Acta Oncol (2005) 1.53

Optimizing the design of web-based questionnaires--experience from a population-based study among 50,000 women. Eur J Epidemiol (2007) 1.51

Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res (2009) 1.51

Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst (2012) 1.50

Coffee consumption and circulating B-vitamins in healthy middle-aged men and women. Clin Chem (2008) 1.48

Which tool is best for colorectal cancer screening? BMJ (2010) 1.47

Consumption of fish products across the lifespan and prostate cancer risk. PLoS One (2013) 1.46

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res (2007) 1.45

Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer (2005) 1.45

mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol (2011) 1.40

Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr (2006) 1.40

A global assessment of the oesophageal adenocarcinoma epidemic. Gut (2012) 1.40

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.39

[Colorectal cancer--a disease one doesn't talk about]. Tidsskr Nor Laegeforen (2007) 1.39

[Implementation of guidelines for PSA testing in general practice]. Tidsskr Nor Laegeforen (2014) 1.39

LifeGene--a large prospective population-based study of global relevance. Eur J Epidemiol (2010) 1.38

[Unexpected findings--sunlight can protect against cancer]. Lakartidningen (2005) 1.38

Norwegian mammography screening - numerous self-contradictions in the evaluation. Tidsskr Nor Laegeforen (2016) 1.38

Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst (2007) 1.37

Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol (2013) 1.35

Screening for prostate cancer remains controversial. BMJ (2009) 1.34

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev (2005) 1.33

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate (2009) 1.33

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res (2004) 1.32

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell (2010) 1.29

Dietary factors and risk of non-hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev (2005) 1.29

Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst (2005) 1.29

Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer (2008) 1.28

Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol (2006) 1.28

Hepatitis C infection and risk of malignant lymphoma. Int J Cancer (2008) 1.27